{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:11:14Z","timestamp":1784128274319,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Kepler University Linz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      Severe pulmonary tularaemia is rare, and evidence guiding optimal antimicrobial treatment remains limited. Although aminoglycosides are commonly recommended, their toxicity profile and practical limitations may complicate treatments. The purpose of this case series was to describe clinical outcomes in adult patients with severe pulmonary tularaemia caused by\n                      <jats:italic>Francisella tularensis<\/jats:italic>\n                      who were treated with fluoroquinolones or tetracyclines.;\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively describe six adult patients with severe pulmonary tularaemia. Clinical presentation, antimicrobial treatment, and clinical and radiological outcomes were reviewed, with a focus on response to targeted therapy with fluoroquinolones or tetracyclines.;<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All six patients achieved complete clinical and radiological recovery following targeted antimicrobial therapy with either fluoroquinolones or tetracyclines despite severe pulmonary disease.;<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case series provides consistent real-world evidence that fluoroquinolones and tetracyclines can achieve favourable outcomes in severe pulmonary tularaemia. These findings highlight their potential role as alternative treatment strategies and contribute meaningful data to the ongoing discussion on optimal antimicrobial management of tularaemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-026-02854-3","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:53:29Z","timestamp":1784127209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aminoglycosides: Is there an effective alternative in severe tularaemia? A case series"],"prefix":"10.1007","author":[{"given":"Markus","family":"Fiedler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias J.","family":"Neub\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Eimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Ablinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Murauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut J. F.","family":"Salzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Rolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"10","key":"2854_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101597","volume":"8","author":"S Seiwald","year":"2020","unstructured":"Seiwald S, Simeon A, Hofer E, Weiss G, Bellmann-Weiler R. Tularemia goes West: epidemiology of an emerging infection in Austria. Microorganisms. 2020;8(10):1597. https:\/\/doi.org\/10.3390\/microorganisms8101597.","journal-title":"Microorganisms"},{"issue":"Supplement_1","key":"2854_CR2","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/cid\/ciad736","volume":"78","author":"CA Nelson","year":"2024","unstructured":"Nelson CA, Winberg J, Bostic TD, Davis KM, Fleck-Derderian S. Systematic review: clinical features, antimicrobial treatment, and outcomes of human tularemia, 1993\u20132023. Clin Infect Dis. 2024;78(Supplement_1):S15\u201328. https:\/\/doi.org\/10.1093\/cid\/ciad736.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2854_CR3","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/cid\/ciae098","volume":"78","author":"M Plymoth","year":"2024","unstructured":"Plymoth M, Lundqvist R, Nystedt A, Sj\u00f6stedt A, Gustafsson TN. Targeting Tularemia: clinical, laboratory, and treatment outcomes from an 11-year retrospective observational cohort in Northern Sweden. Clin Infect Dis. 2024;78(5):1222\u201331. https:\/\/doi.org\/10.1093\/cid\/ciae098.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2854_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4121-1","volume":"19","author":"S Esmaeili","year":"2019","unstructured":"Esmaeili S, Ghasemi A, Naserifar R, et al. Epidemiological survey of Tularemia in Ilam Province, west of Iran. BMC Infect Dis. 2019;19(1):502. https:\/\/doi.org\/10.1186\/s12879-019-4121-1.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2854_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1473-3099(15)00355-2","volume":"16","author":"M Maurin","year":"2016","unstructured":"Maurin M, Gyuranecz M. Tularaemia: clinical aspects in Europe. Lancet Infect Dis. 2016;16(1):113\u201324. https:\/\/doi.org\/10.1016\/S1473-3099(15)00355-2.","journal-title":"Lancet Infect Dis"},{"key":"2854_CR6","unstructured":"Jahresbericht+2024. https:\/\/www.sozialministerium.gv.at\/Themen\/Gesundheit\/Uebertragbare-Krankheiten\/Statistiken-und-Fallzahlen.html"},{"issue":"1","key":"2854_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12879-020-05051-1","volume":"20","author":"L Antonitsch","year":"2020","unstructured":"Antonitsch L, Weidinger G, Stanek G, Markowicz M. Francisella tularensis as the cause of protracted fever. BMC Infect Dis. 2020;20(1):327. https:\/\/doi.org\/10.1186\/s12879-020-05051-1.","journal-title":"BMC Infect Dis"},{"key":"2854_CR8","unstructured":"Tickborne Diseases of the United States: A Reference Manual for Healthcare Providers, Sixth Edition, 2022."},{"issue":"2","key":"2854_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01393-23","volume":"68","author":"E Shin","year":"2024","unstructured":"Shin E, Zhang Y, Zhou J, et al. Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrob Agents Chemother. 2024;68(2):e01393-23. https:\/\/doi.org\/10.1128\/aac.01393-23.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2854_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0009-9236(99)70103-7","volume":"65","author":"A Carcas","year":"1999","unstructured":"Carcas A, Garciasatue J, Zapater P, Friasiniesta J. Tobramycin penetration into epithelial lining fluid of patients with pneumonia. Clin Pharmacol Ther. 1999;65(3):245\u201350. https:\/\/doi.org\/10.1016\/S0009-9236(99)70103-7.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2854_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/ALN.0000000000002752","volume":"131","author":"JA Dhanani","year":"2019","unstructured":"Dhanani JA, Diab S, Chaudhary J, et al. Lung pharmacokinetics of tobramycin by intravenous and nebulized dosing in a mechanically ventilated healthy ovine model. Anesthesiology. 2019;131(2):344\u201355. https:\/\/doi.org\/10.1097\/ALN.0000000000002752.","journal-title":"Anesthesiology"},{"issue":"1","key":"2854_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40262-021-01061-7","volume":"61","author":"EN Drwiega","year":"2022","unstructured":"Drwiega EN, Rodvold KA. Penetration of antibacterial agents into pulmonary epithelial lining fluid: an update. Clin Pharmacokinet. 2022;61(1):17\u201346. https:\/\/doi.org\/10.1007\/s40262-021-01061-7.","journal-title":"Clin Pharmacokinet"},{"issue":"Supplement_1","key":"2854_CR13","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/cid\/ciad690","volume":"78","author":"M Widerstr\u00f6m","year":"2024","unstructured":"Widerstr\u00f6m M, M\u00f6rtberg S, Magnusson M, Fj\u00e4llstr\u00f6m P, Johansson AF. Treatment outcome of severe respiratory type B tularemia using fluoroquinolones. Clin Infect Dis. 2024;78(Supplement_1):S38\u201346. https:\/\/doi.org\/10.1093\/cid\/ciad690.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2854_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7402a1","volume":"74","author":"CA Nelson","year":"2025","unstructured":"Nelson CA, Meaney-Delman D, Fleck-Derderian S, Winberg J, Mead PS. Tularemia antimicrobial treatment and prophylaxis: CDC recommendations for naturally acquired infections and bioterrorism response - United States, 2025. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2025;74(2):1\u201333. https:\/\/doi.org\/10.15585\/mmwr.rr7402a1.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"issue":"1","key":"2854_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0463.2008.00901.x","volume":"116","author":"M Meric","year":"2008","unstructured":"Meric M, Willke A, Finke EJ, et al. Evaluation of clinical, laboratory, and therapeutic features of 145 Tularemia cases: the role of quinolones in oropharyngeal Tularemia. APMIS. 2008;116(1):66\u201373. https:\/\/doi.org\/10.1111\/j.1600-0463.2008.00901.x.","journal-title":"APMIS"},{"issue":"5","key":"2854_CR16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38920","volume":"15","author":"UD Binay","year":"2023","unstructured":"Binay UD, Barkay O, Karake\u00e7ili F. Tularemia in the differential diagnosis of lymphadenitis: a retrospective analysis of 16 cases. Cureus. 2023;15(5):e38920. https:\/\/doi.org\/10.7759\/cureus.38920.","journal-title":"Cureus"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02854-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02854-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02854-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:53:30Z","timestamp":1784127210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02854-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":16,"alternative-id":["2854"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02854-3","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}